or Try an Advanced Search...

    Angina Stocks List

    Symbol Grade Name % Change
    GILD C Gilead Sciences, Inc. 1.27
    MIST C Milestone Pharmaceuticals Inc. -0.54
    ALKS C Alkermes plc -0.75
    LSTA D Lisata Therapeutics, Inc. -2.94
    AZN F Astrazeneca PLC 1.68
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Hypertension Cholesterol Chronic Kidney Disease Coronavirus Depressive Disorder Disease Infection Inflammation Nasdaq 100 Organic Chemistry Respiratory Diseases Schizophrenia Acid Alcohol Anemia Antibiotics Antibodies Asthma Atrial Fibrillation

    Related ETFs - A few ETFs which own one or more of the above listed Angina stocks.

    Symbol Grade Name Weight
    IBBQ D Invesco Nasdaq Biotechnology ETF 14.42
    BIB F ProShares Ultra Nasdaq Biotechnology 10.9
    BBH D Market Vectors Biotech ETF 10.89
    IBB D iShares Nasdaq Biotechnology Index Fund 10.23
    MEDX F Horizon Kinetics Medical ETF 8.77
    View all Angina ETFs...
    Compare ETFs
    Compare BIB to IBB Compare IBBQ to IBB Compare IBBQ to MEDX

        Angina Stocks Recent News

        Date Stock Title
        Nov 21 AZN AstraZeneca's Andexxa Faces FDA Scrutiny Over Effectiveness, Safety Concerns
        Nov 21 AZN Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
        Nov 21 ALKS Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?
        Nov 21 AZN We Think AstraZeneca's (LON:AZN) Healthy Earnings Might Be Conservative
        Nov 21 AZN 3 Growth Stocks Trading Near Their 52-Week Lows to Buy Right Now
        Nov 21 AZN AstraZeneca upgraded to Neutral from Sell at UBS
        Nov 21 AZN AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg
        Nov 20 GILD Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference (Transcript)
        Nov 20 AZN AstraZeneca raised to neutral at UBS despite China headwinds
        Nov 20 AZN AstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the US
        Nov 20 AZN Daiichi Sankyo and AstraZeneca’s Enhertu snubbed by UK’s NICE for third time
        Nov 20 AZN AstraZeneca Is No Longer a Sell for Any Analyst as UBS Upgrades
        Nov 20 AZN FTSE 100 and European-listed stocks to own in 2025, according to Barclays
        Nov 19 MIST After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
        Nov 19 LSTA Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
        Nov 19 AZN CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
        Nov 19 AZN AstraZeneca’s Tagrisso recommended for approval in EU by CHMP for certain NSCLC
        Nov 19 AZN CHMP recommends AstraZeneca’s Tagrisso for EU approval for NSCLC
        Nov 18 AZN GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
        Nov 18 AZN AstraZeneca picks first Treg cell therapy from Quell Therapeutics partnership
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Hypertension Cholesterol Chronic Kidney Disease Coronavirus Depressive Disorder Disease Infection Inflammation Nasdaq 100 Organic Chemistry Respiratory Diseases Schizophrenia Acid Alcohol Anemia Antibiotics Antibodies Asthma Atrial Fibrillation
        Angina

        Angina, also known as angina pectoris, is chest pain or pressure, usually due to not enough blood flow to the heart muscle.
        Angina is usually due to obstruction or spasm of the coronary arteries. Other causes include anemia, abnormal heart rhythms and heart failure. The main mechanism of coronary artery obstruction is an atherosclerosis as part of coronary artery disease. The term derives from the Latin angere ("to strangle") and pectus ("chest"), and can therefore be translated as "a strangling feeling in the chest".

        More about Angina
        Browse All Tags